Fabbri C, Luigiano C, Cennamo V, Ferrara F, Pellicano R, Polifemo A M, Tarantino I, Barresi L, Morace C, Consolo P, D'Imperio N
Unit of Gastroenterology and Digestive Endoscopy, AUSL Bologna, Bellaria-Maggiore Hospital, Bologna, Italy.
Minerva Gastroenterol Dietol. 2011 Jun;57(2):159-66.
Since its development in the 1980s, endoscopic ultrasonography (EUS) has undergone a great deal of technological modifications. EUS has become an important tool in the evaluation of patients with various clinical disorders and is increasingly being utilized in many centers. EUS has been evolving over the years; EUS-guided fine needle aspiration (FNA) for cytological and/or histological diagnosis has become standard practice and a wide array of interventional and therapeutic procedures are performed under EUS guidance for diseases which otherwise would have needed surgery, with its associated morbidities. EUS shares the risks and complications of other endoscopic procedures. This article addresses the specific adverse effects and risks associated with EUS, EUS-FNA and interventional EUS, namely perforation, bleeding, pancreatitis and infection. Measures to help minimizing these risks will also be discussed.
自20世纪80年代内镜超声检查(EUS)问世以来,它经历了大量的技术改进。EUS已成为评估各种临床疾病患者的重要工具,并且在许多中心越来越多地得到应用。多年来EUS一直在不断发展;用于细胞学和/或组织学诊断的EUS引导下细针穿刺抽吸术(FNA)已成为标准操作,并且在EUS引导下针对原本需要手术及其相关并发症的疾病开展了一系列介入和治疗程序。EUS具有其他内镜检查程序的风险和并发症。本文探讨了与EUS、EUS-FNA和介入性EUS相关的特定不良反应和风险,即穿孔、出血、胰腺炎和感染。还将讨论有助于将这些风险降至最低的措施。